Market Tracker

06/24 6:45pm ET

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

18.44
Delayed Data
As of 4:00pm ET
 -0.68 / -3.56%
Today’s Change
9.51
Today|||52-Week Range
23.30
+37.20%
Year-to-Date
No recent news for Supernus Pharmaceuticals Inc.

Today’s Trading

Previous close19.12
Today’s open18.32
Day’s range17.93 - 18.86
Volume2,080,044
Average volume (3 months)647,025
Market cap$944.9M
Dividend yield--
Data as of 4:00pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)-12.50%
Earnings growth (this year)+125.51%
Earnings growth (next 5 years)+53.00%
Revenue growth (last year)+18.34%
P/E ratio53.8
Price/Sales4.76
Price/Book7.88

Competitors

 Today’s
change
Today’s
% change
INSYINSYS Therapeutics I...-0.45-3.44%
LCILannett Company Inc-0.92-3.66%
MGNXMacroGenics Inc-2.26-8.56%
SAGESAGE Therapeutics In...-2.26-7.34%
Data as of 4:01pm ET, 06/24/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)$0.13
Annual revenue (last year)$144.4M
Annual profit (last year)$14.0M
Net profit margin9.70%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Director &
Secretary
Jack A. Khattar
CFO, Vice President &
Head-Investor Relations
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts